surmount-1 trial tirzepatide obesity without diabetes once weekly for the treatment of in people with type 2 (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 Tirzepatide Demonstrates 94% Diabetes Reduction,
Pay in 4 interest-free payments of $7.34 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 7 - Sep 12






















![Agumon [EX9-007] (Digital Monster Day Commemoration Event Participant) [Promotional Cards]](https://tcg.goodgames.com.au/cdn/shop/files/639462_800x.jpg?v=1771355779)


